Cell Culture Media Market: Industry Analysis and Forecast (2024-2030) Trends, Statistics, Dynamics, Segmentation by Product Type, Application, End-User and Region

Cell Culture Media Market Overview:

The Cell Culture Media market is segmented into product type, application, end-user and region. On the basis of product type, the Cell Culture Media Market is segmented into Classical Media & Salts, HEK 293 Media, BHK Media, Specialty Media, Serum-free Media, CHO Media, Serum-free Stem Cell Media, Insect Cell Media, CAR T-cell Media, Other Serum-free Media, VERO Cell Media, Stem Cell Culture Media, chemically defined Media and Other Cell Culture Media. On the basis of application, the market is segmented into Diagnostics, Vaccines production, Monoclonal antibodies, Other therapeutic proteins, Biopharmaceutical Production, Drug Screening & Development, Other tissue engineering & regenerative medicine applications, Cell and gene therapy, Tissue Engineering & Regenerative Medicine and Other Applications. On the basis of end-user, the market is segmented into Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes and Other End Users. Geographically the Cell Culture Media Market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America.

 

 

To get more Insights: Request Free Sample Report

 

Cell Culture Media Market Dynamics:

Cell Culture Media market is projected to witness significant growth rate as it has become an important aspect of vaccine manufacture in the pharmaceutical business owing to which it is projected to witness significant growth rate during the forecast period. Vaccines for rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox have all been developed using cell culture technology and hence showcase the importance of its existence in the biotechnological space.

 

In the United States and many European nations, cell-based flu vaccines have also been approved for use which are a product of cell culture. One of the most important procedures in the life sciences is cell culture. It refers to the process of removing cells, tissues, or organs from an animal or plant and placing them in an artificial environment that promotes their survival and/or multiplication. Controlled temperature, a substrate for cell attachment, and an adequate growth medium and incubator that maintains proper pH and osmolality are the basic environmental needs for cells to develop properly. The selection of proper growth media for in vitro cultivation is the most significant and crucial phase in cell culture. A growth medium, also known as a culture media, is a liquid or gel that helps bacteria, cells, or miniature plants develop. In general, cell culture mediums contain an adequate amount of energy as well as chemicals that regulate the cell cycle. A normal culture media contains amino acids, vitamins, inorganic salts, glucose, and serum, which contains growth factors, hormones, and attachment factors. Aside from providing nutrients, the medium also aids in maintaining pH and osmolality.

 

Earlier, vaccinations were made by cultivating and extracting viruses in chicken eggs, which took a long period.

 

Cell culture-based vaccine manufacture, on the other hand, is a significantly more efficient process. Shorter lead times and the capacity to create vaccines in bigger numbers on demand are two of its advantages over traditional manufacturing processes. Furthermore, cell culture-based vaccinations can be kept for longer periods of time. Cell-based vaccines provided better protection against flu-related hospitalizations than standard-dose egg-based vaccines among Medicare beneficiaries 65 and older, according to a study published by the CDC in the Journal of Infectious Diseases (June 2020). All four flu viruses employed in Flucelvax Quadrivalent for the 2020-2021 flu season were derived from Cell Culture Media process. As a result, there has been a spike in cell-based vaccinations in recent years, prompting major corporations to try to cash in on the prospects. For example, Seqirus has worked in this area as it was the first vaccine manufacturer that made cell-based influenza vaccine on a commercial scale with cultivating them inside eggs. The setup used was rather cell-based candidate vaccine virus (CVV). The process of cell based CVVs leads to improved process control and higher yields as compared to conventional methods and hence a strong candidate to replace the existing system.

 

In terms of restraints, animal and human cells are employed in gene therapy studies that entail recombination of genes and stem cell research therapies, which necessitates the use of animals and humans in cell biology research. These cells are also utilized to evaluate medicines for in vivo toxicity and pharmacokinetics in animals and humans. Furthermore, stem cell research uses human embryos for clinical purposes, which frequently results in the killing of human embryos. Strict restrictions have been created by ethical authorities in numerous nations across the world to supervise these operations. Stringent regulations for cell biology research have been implemented by authorities such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others. These ethical concerns and limits on the use of cells in research are severely restricting cell biology research in many nations throughout the world. As a result, demand for cell culture goods, such as cell culture medium, is likely to decline.

 

As there is rising prevalence of chronic diseases, improvements in research infrastructure, and favorable legislation for cell-based research, several market participants are investing in the construction of cell-based research facilities in emerging Asian countries. Furthermore, India is a desirable place for cell culture media firms, owing to increased government investments in high-tech facilities for cell-based research, the availability of highly skilled workforce, and the low-cost manufacturing advantage. Another factor that is driving the Cell Culture Media Market forward is its impact in diagnosis of several health conditions. For instance, in patients with acute respiratory distress syndrome (ARDS), cell-based therapies, especially using mesenchymal stromal cells (MSCs), have exhibited a great safety profile and likely efficacy.

 

Additionally, clinical trials of mesenchymal stromal cells-based cell treatment techniques have been underway since the outbreak of COVID-19, with an increasing number of university and industry trials. In the investigation of the novel virus, cell culture medium will be crucial. The Indian Department of Pharmaceuticals has created a document called "Pharma Vision 2020" with the goal of making India a prominent destination for drug discovery and development. Owing to these advantages, biopharmaceutical and pharmaceutical companies are rapidly outsourcing drug discovery to nations like India and China, which is promoting the use of cell culture medium products in research. Because of these advantages, biopharmaceutical and pharmaceutical companies are rapidly outsourcing drug discovery to nations like India and China, which is promoting the use of cell culture medium products in research.

 

Cell Culture Media Market Segment Analysis:

On the basis of product type, Serum free media segment is projected to dominate the cell culture media market during the forecast period. The market dominance of serum free media segment is attributed to the advantages that it offers like easier purification and downstream processing, increased definition and more reproducible formulations, allowing for more convincing and consistent research results, elimination of time-consuming batch tests and lower risk of contamination with bacteria, fungi or virus.

 

By End-User, the pharmaceuticals and biotechnology company segment is projected to grow at a significant rate and also dominate the Cell Culture and Media market during the forecast period. This is due to widespread use of Cell Culture technology for developing vaccines in the pharmaceutical industry. Almost all major vaccines like rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox have been developed using Cell Culture Media. The volume of demand from such biotechnological and pharmaceutical companies is driving the growth of Cell Culture and Media market upwards. Additionally, the Cell Culture Media market is being driven by the increasing usage of single-use technologies, the increasing number of regulatory approvals for culture-based vaccines, and the presence of a significant number of pharmaceutical manufacturers in this market.

 

By Application, the biopharmaceutical production segment is projected to dominate the Cell Culture Media Market owing to the large-scale demand from the biopharmaceutical companies for vaccine development in their facilities. Diagnostics and Drugs Screening and Development segments are also projected to grow at a significant rate during the forecast period. This is due to the versatility of the Cell Culture Media market products that can be used in many applications.

 

 

Cell Culture Media Market Regional Insights:

North America region is projected to witness significant growth rate during the forecast period. This is due to increasing number of regulatory compliances that all the biotechnological and pharmaceutical manufacturers have to adhere for cell-based vaccines. Additionally, the key players in the North American region are investing heavily in research and development of Cell Culture Media technology as this technology can help in controlling process output of biotechnological systems along with cost control.

 

The Asia-Pacific regions is projected to grow at a significant rate during the forecast period due to growing pharmaceutical sector that consumes majority of the output of the Cell Culture Media Market. As pharmaceutical sector grows in the region so will the demand for Cell Culture Media technology and hence improving the same has become priority for key players in the Cell Culture Media market. South America and Middle East and Africa region are projected to experience stagnant growth due to absence of key players in the respective region along with absence of pharma industries as well. Specifically, Europe region is projected to witness mild growth during the forecast period due to increased investment by governments in the region to reduce the impact of diabetes that is prevalent in the European region.

 

The objective of the report is to present a comprehensive analysis of the Cell Culture Media market to the stakeholders in the industry. The report provides trends that are most dominant in the Cell Culture Media market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the Cell Culture Media Market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

 

The qualitative and quantitative data provided in the Cell Culture Media market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Cell Culture Media market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the Cell Culture Media market.

 

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals exist, who they are, and how their product quality is in the Cell Culture Media market. The report also analyses if the Cell Culture Media market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly, if the market is dominated by a few players, etc.

 

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Cell Culture Media market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Cell Culture Media market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Cell Culture Media market is aided by legal factors.

 

Cell Culture Media Market Scope:

Cell Culture Media Market
Market Size in 2023	USD 12.75 Bn.
Market Size in 2030	USD 29.44 Bn.
CAGR (2024-2030)	12.7%
Historic Data	2018-2022
Base Year	2023
Forecast Period	2024-2030
Segment Scope	By Product Type Classical Media & Salts HEK 293 Media BHK Media Specialty Media Serum-free Media CHO Media Serum-free Stem Cell Media Insect Cell Media CAR T-cell Media Other Serum-free Media VERO Cell Media Stem Cell Culture Media Chemically defined Media Other Cell Culture Media
	By Application Diagnostics Vaccines production Monoclonal antibodies Other therapeutic proteins Biopharmaceutical Production Drug Screening & Development Othertissueengineering regenerativemedicine applications Cell and gene therapy TissueEngineering& Regenerative Medicine Other Applications
	By End-User Hospitals&Diagnostic Laboratories Pharmaceutical & Biotechnology Companies Research & Academic Institutes Other End Users
Regional Scope	North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America

 

 

Cell Culture Media Market Key Players

• Thermo Fisher Scientific (US)
• InvivoGen (France)
• Danaher Corporation (US)
• Akron Biotech (US)
• Merck KGaA (Germany)
• Sartorius AG (Germany)
• Corning Incorporated (US)
• FUJIFILM Irvine Scientific Inc (Japan)
• Lonza Group AG (Switzerland)
• Cell Applications, Inc. (US)
• Becton, Dickinson and Company (US)
• Miltenyi Biotec (Germany)
• HiMedia Laboratories Pvt. Ltd. (India)
• STEMCELL Technologies Inc. (Canada)
• Cell Applications, Inc. (US)
• Pan-Biotech GmbH (Germany)
• ZenBio Inc. (US)